ArTara Therapeutics, Inc.
ArTara Therapeutics, Inc. (TARA) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 181 transactions totaling $5.6M, demonstrating a bearish sentiment with -$1.6M in net insider flow. The most recent transaction on Jan 16, 2026 involved a transaction of 158,000 shares valued at $0.
TARA Insider Activity Summary
Who Is Buying TARA Stock?
No significant insider buying has been recorded for TARA in the recent period.
Who Is Selling TARA Stock?
No significant insider selling has been recorded for TARA in the recent period.
Is ArTara Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TARA is bearish with an Insider Alignment Score of 36/100 and a net flow of -$1.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
TARA Frequently Asked Questions
Understanding TARA Insider Activity
Insider trading at ArTara Therapeutics, Inc. (TARA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading TARA stock, having executed 181 transactions in the past 90 days. The most active insider is L.p. Opaleye, (Executive), who has made 2 transactions totaling $10.0M.
Related Tools
Track ArTara Therapeutics, Inc. Insider Activity
Get notified when executives and directors at TARA file new Form 4 transactions